74 302

Cited 38 times in

Therapeutic responses and prognosis in adult-onset Still's disease

Kim, HA; Sung, JM; Suh, CH
Rheumatology international, 32(5):1291-1298, 2012
Journal Title
Rheumatology international
To date, the treatment of adult-onset Still's disease (AOSD) has been largely empirical; therefore, this study was conducted to investigate the response to therapy and prognostic factors of AOSD. Fifty-four Korean patients with AOSD were enrolled based on Yamaguchi's criteria. We retrospectively analyzed the treatments and prognosis. Thirty-nine patients (72.2%) were female, and the average age at disease onset was 37.3 years. Twenty-nine patients had a monocyclic disease (53.7%), five had a polycyclic (9.3%) and fifteen had a chronic articular disease (27.7%) and five died (9.3%). The elevated ESR and corticosteroids refractoriness were associated with poor prognosis (P = 0.023 and P = 0.009, respectively). The patients that died were older than those survived (49.2 ± 11.8 vs. 42.2 ± 14 year old, P = 0.024). Forty-two patients were treated with non-steroidal anti-inflammatory drugs; however, they also needed corticosteroids and intravenous immunoglobulin (IVIG). Among 50 patients treated with high-dose corticosteroids, 21 patients (42%) were resistant to corticosteroids and treated with IVIG or anti-tumor necrosis factor (TNF) agents. Of the 23 patients medicated with IVIG, the prognosis was better in IVIG-responsive patients, indicating a therapeutic effect. Methotrexate was the most commonly used disease modifying anti-rheumatic drugs (27 patients, 50%), and the corticosteroid requirements were lower in the methotrexate-responsive patients. Approximately half of AOSD patients had a poor prognosis and were corticosteroids resistance. An elevated ESR and non-response to corticosteroids were associated with poor prognosis. Patients who died were older than those survived.
MeSH terms
Adrenal Cortex Hormones/*therapeutic useAdultAge FactorsAnti-Inflammatory Agents, Non-Steroidal/*therapeutic useBlood SedimentationChi-Square DistributionDrug ResistanceDrug Therapy, CombinationFemaleHumansImmunoglobulins, Intravenous/*therapeutic useImmunosuppressive Agents/*therapeutic useMaleMiddle AgedPredictive Value of TestsRepublic of KoreaRetrospective StudiesRisk AssessmentRisk FactorsStill's Disease, Adult-Onset/complications/diagnosis/*drug therapy/mortalitySurvival AnalysisTime FactorsTreatment Outcome
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Rheumatology
AJOU Authors
김, 현아서, 창희
Files in This Item:
fulltext not available.txtDownload
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.